Mackay Shields LLC’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Mackay Shields LLC’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,100	Closed	-$219K	–	1411
2021 Q1	$219K	Sell	12,100 -16,800	-58%	-$332K	﹤0.01%	1394
2020 Q4	$527K	Sell	28,900 -61,600	-68%	-$977K	﹤0.01%	1247
2020 Q3	$1.15M	Buy	90,500 +64,200	+244%	+$820K	0.01%	986
2020 Q2	$289K	Sell	26,300 -2,827	-10%	-$29.3K	﹤0.01%	1302
2020 Q1	$304K	Sell	29,127 -166,800	-85%	-$2.15M	﹤0.01%	1220
2019 Q4	$3.15M	Buy	195,927 +96,000	+96%	+$1.59M	0.02%	688
2019 Q3	$1.57M	Sell	99,927 -104,600	-51%	-$1.74M	0.01%	998
2019 Q2	$4.07M	Buy	204,527 +131,135	+179%	+$2.45M	0.03%	607
2019 Q1	$1.24M	Buy	+73,392	New	+$1.27M	0.01%	924
2018 Q2	–	Sell	-15,900	Closed	-$217K	–	1319
2018 Q1	$217K	Buy	+15,900	New	+$209K	﹤0.01%	1207

Other funds holding NXGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Mackay Shields LLC's NXGN Position: Q2 2021 in Review

Mackay Shields LLC sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2021, closing a stake of 12,100 shares — an estimated $219K sold.

Mackay Shields LLC first reported a position in NXGN in Q1 2018 and held it in 10 quarters. The position peaked at $4.07M in Q2 2019. 164 funds tracked by Wall St. Rank hold NXGN as of Q2 2021.

Mackay Shields LLC reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 12,100 NextGen Healthcare, Inc. Common Stock shares in Q2 2021, an estimated $219K.
Mackay Shields LLC first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2018 and held it in 10 quarters.
Mackay Shields LLC's NextGen Healthcare, Inc. Common Stock position peaked at $4.07M in Q2 2019.
164 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.